back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-13 15:31 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$68,290
+1,365,800 vol $0.05 each |
1,365,800 | |
| Filed 2023-01-13 15:31 Tx date 2021-04-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:30 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$68,290
+1,365,800 vol $0.05 each |
1,365,800 | |
| Filed 2023-01-13 15:30 Tx date 2021-04-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:28 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$106,703
+2,134,062 vol $0.05 each |
2,134,062 | |
| Filed 2023-01-13 15:27 Tx date 2021-04-04 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:23 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$106,703
+2,134,062 vol $0.05 each |
2,134,062 | |
| Filed 2023-01-13 15:22 Tx date 2021-04-04 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:31 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 16:30 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:28 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 16:27 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:22 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 16:20 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 16:19 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$254,902
+5,098,042 vol $0.05 each |
5,098,042 | |
| Filed 2023-01-12 14:30 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1K Capital Partners LLC (Indirect Ownership)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 14:19 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$66,395
+1,327,900 vol $0.05 each |
1,327,900 | |
| Filed 2023-01-12 14:13 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-12 14:10 Tx date 2023-01-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
16 - Acquisition or disposition under a prospectus exemption
|
$66,395
+1,327,900 vol $0.05 each |
1,327,900 | |
| Filed 2023-01-12 14:09 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-03 13:17 Tx date 2022-06-02 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
-350,000 vol |
0 | |
| Filed 2022-06-03 13:16 Tx date 2022-05-13 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,600
+80,000 vol $0.07 each |
350,000 | |
| Filed 2022-06-03 13:14 Tx date 2022-05-12 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,300
+200,000 vol $0.0665 each |
270,000 | |
| Filed 2022-06-03 13:13 Tx date 2022-05-11 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,600
+70,000 vol $0.08 each |
70,000 | |
| Filed 2022-05-06 09:42 Tx date 2022-05-02 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
-885,000 vol |
0 | |
| Filed 2022-05-06 09:42 Tx date 2022-04-25 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$900.00
+10,000 vol $0.09 each |
885,000 | |
| Filed 2022-05-06 09:41 Tx date 2022-04-22 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,260
+108,000 vol $0.095 each |
875,000 | |
| Filed 2022-05-06 09:40 Tx date 2022-04-21 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,085
+43,000 vol $0.095 each |
767,000 | |
| Filed 2022-05-06 09:40 Tx date 2022-04-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,060
+34,000 vol $0.09 each |
724,000 | |
| Filed 2022-05-06 09:39 Tx date 2022-04-18 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,200
+80,000 vol $0.09 each |
690,000 | |
| Filed 2022-05-06 09:38 Tx date 2022-04-14 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,000
+100,000 vol $0.09 each |
610,000 | |
| Filed 2022-05-06 09:38 Tx date 2022-04-13 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,100
+90,000 vol $0.09 each |
510,000 | |
| Filed 2022-05-06 09:37 Tx date 2022-04-12 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,100
+90,000 vol $0.09 each |
420,000 | |
| Filed 2022-05-06 09:36 Tx date 2022-04-11 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,100
+90,000 vol $0.09 each |
330,000 | |
| Filed 2022-05-06 09:35 Tx date 2022-04-08 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,005
+153,000 vol $0.085 each |
240,000 | |
| Filed 2022-05-06 09:35 Tx date 2022-04-07 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,960
+87,000 vol $0.08 each |
87,000 | |
| Filed 2022-04-06 10:48 Tx date 2022-03-31 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-56,280
-469,000 vol $0.12 each |
5,711,000 | |
| Filed 2022-04-06 10:48 Tx date 2022-03-30 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-20,280
-156,000 vol $0.13 each |
6,180,000 | |
| Filed 2022-04-06 10:47 Tx date 2022-03-29 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-37,245
-286,500 vol $0.13 each |
6,336,000 | |
| Filed 2022-04-06 10:47 Tx date 2022-03-28 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-20,865
-160,500 vol $0.13 each |
6,622,500 | |
| Filed 2022-04-06 10:46 Tx date 2022-03-25 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-13,200
-110,000 vol $0.12 each |
6,783,000 | |
| Filed 2022-04-06 10:45 Tx date 2022-03-24 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-4,355
-33,500 vol $0.13 each |
6,893,000 | |
| Filed 2022-04-06 10:45 Tx date 2022-03-23 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-13,000
-100,000 vol $0.13 each |
6,926,500 | |
| Filed 2022-04-06 10:44 Tx date 2022-03-23 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-280.00
-2,000 vol $0.14 each |
7,026,500 | |
| Filed 2022-04-06 10:44 Tx date 2022-03-22 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-9,600
-64,000 vol $0.15 each |
7,028,500 | |
| Filed 2022-04-06 10:43 Tx date 2022-03-21 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-1,050
-7,000 vol $0.15 each |
7,092,500 | |
| Filed 2022-04-06 10:42 Tx date 2022-03-18 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-1,840
-11,500 vol $0.16 each |
7,099,500 | |
| Filed 2022-04-06 10:41 Tx date 2022-03-16 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-5,440
-32,000 vol $0.17 each |
7,111,000 | |
| Filed 2022-02-08 14:26 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
OrbiMed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Genesis Master Fund, L.P. (Control or Direction)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
7,143,000 | ||
| Filed 2022-01-28 14:53 Tx date 2022-01-27 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
-387,000 vol |
0 | |
| Filed 2022-01-28 14:52 Tx date 2021-12-30 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,125
+25,000 vol $0.245 each |
387,000 | |
| Filed 2022-01-28 14:51 Tx date 2021-12-24 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,625
+25,000 vol $0.225 each |
362,000 | |
| Filed 2022-01-28 14:51 Tx date 2021-12-23 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,755
+33,000 vol $0.235 each |
337,000 | |
| Filed 2022-01-28 14:50 Tx date 2021-12-22 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,050
+35,000 vol $0.23 each |
304,000 | |
| Filed 2022-01-28 14:49 Tx date 2021-12-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,750
+25,000 vol $0.23 each |
269,000 | |
| Filed 2022-01-28 14:48 Tx date 2021-12-07 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,900
+163,000 vol $0.30 each |
244,000 | |
| Filed 2022-01-28 14:47 Tx date 2021-12-03 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,500
+75,000 vol $0.30 each |
81,000 | |
| Filed 2022-01-28 14:46 Tx date 2021-12-03 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,800
+6,000 vol $0.30 each |
6,000 | |
| Filed 2021-11-10 12:37 Tx date 2021-11-01 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
-397,500 vol |
0 | |
| Filed 2021-11-10 12:36 Tx date 2021-10-28 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,920
+28,000 vol $0.39 each |
397,500 | |
| Filed 2021-11-10 12:36 Tx date 2021-10-27 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,725
+45,000 vol $0.305 each |
369,500 | |
| Filed 2021-11-10 12:35 Tx date 2021-10-22 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,000
+80,000 vol $0.30 each |
324,500 | |
| Filed 2021-11-10 12:34 Tx date 2021-10-21 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,287
+7,500 vol $0.305 each |
244,500 | |
| Filed 2021-11-10 12:34 Tx date 2021-10-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,327
+4,500 vol $0.295 each |
237,000 | |
| Filed 2021-11-10 12:33 Tx date 2021-10-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,648
+60,000 vol $0.3108 each |
232,500 | |
| Filed 2021-11-10 12:32 Tx date 2021-10-18 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,371
+65,000 vol $0.3134 each |
172,500 | |
| Filed 2021-11-10 12:31 Tx date 2021-10-15 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,600
+42,000 vol $0.30 each |
107,500 | |
| Filed 2021-11-10 12:31 Tx date 2021-10-13 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$150.00
+500 vol $0.30 each |
65,500 | |
| Filed 2021-11-10 12:30 Tx date 2021-10-06 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$135.00
+500 vol $0.27 each |
65,000 | |
| Filed 2021-11-10 12:29 Tx date 2021-10-05 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,044
+15,000 vol $0.2696 each |
64,500 | |
| Filed 2021-11-10 12:27 Tx date 2021-10-04 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,706
+49,500 vol $0.2769 each |
49,500 | |
| Filed 2021-11-10 12:26 Tx date 2021-10-01 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
PsyBio Therapeutics Corp.
1 - Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-23 10:55 Tx date 2021-06-21 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Carmel, Milazzo & Feil LLP (Indirect Ownership)
|
Subordinate Voting Shares
46 - Compensation for services
|
$151,608
+409,752 vol $0.37 each |
409,752 | |
| Filed 2021-06-23 10:54 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Carmel, Ross David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Carmel, Milazzo & Feil LLP (Indirect Ownership)
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-26 17:03 Tx date 2021-04-20 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Oliver, Robert Lee
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2021-04-09 14:20 Tx date 2021-04-04 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Spigarelli, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2021-03-02 11:35 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,970,000 vol |
2,970,000 | |
| Filed 2021-03-02 08:24 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levance Prospects LLC
3 - 10% Security Holder of Issuer
Direct Ownership
|
Multiple Voting Shares
00 - Opening Balance-Initial SEDI Report
|
12,705 | ||
| Filed 2021-03-02 08:10 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-02 08:09 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Levine, Evan Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Levance Prospects LLC (Indirect Ownership)
|
Multiple Voting Shares
00 - Opening Balance-Initial SEDI Report
|
12,705 | ||
| Filed 2021-03-01 11:07 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,476,000 vol |
1,476,000 | |
| Filed 2021-03-01 11:06 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-01 11:05 Tx date 2021-02-19 |
$PSYB
PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) |
Davis, Noah Isidore
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NHJJ Enterprises LLC (Indirect Ownership)
|
Multiple Voting Shares
00 - Opening Balance-Initial SEDI Report
|
5,765 |